{
  "id": 19900501,
  "title": "Julie Rubinstein, Adaptive Biotechnologies COO, sells $1M in stock",
  "url": "https://urgent.news/2026/11/14/julie-rubinstein-adaptive-biotechnologies-coo-sells-1m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-14T01:30:54.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/julie-rubinstein-adaptive-biotechnologies-coo-sells-1m-in-stock-93CH-5026882"
  },
  "original_language": "en",
  "account": null,
  "summary": "Julie Rubinstein, the President and COO of Adaptive Biotechnologies Corp, recently sold a total of approximately $1,047,303 worth of the company's common stock over several transactions in mid-November 2026. These sales were made under a Rule 10b5-1 trading plan and included the exercise of stock options, which were fully vested and exercisable. The reported transactions involved the sale of 23,338 shares at various prices ranging from $28.43 to $31.63. Despite these sales, Adaptive Biotechnologies reported a significant increase in its third-quarter revenue for 2026, reaching $83.9 million, which surpassed Wall Street analysts' expectations. The company's early profitability and the positive reaction in after-hours trading underscore the company's strong financial performance.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}